MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Surgical Technology_Gastrointestinal_GI
Lucid Diagnostics Inc. (NASDAQ: LUCD)
Attachments
Lucid Diagnostics | Biomarkers for Esophageal Cancer | New York
Parents
*Architects: Surgical Technology_Gastrointestinal_GI
*Industry: New York City
Finance & Acquisitions: PAVmed
Organization & Developments: PAVmed
PAVmed Inc. (NASDAQ: PAVM)
Children
2021: Lucid Diagnostics Readies $75 Million IPO
2021: Pavmed acquires CapNostics and its esophageal cell collection device
2025: Lucid Diagnostics signals expanded market reach and $41M pro forma cash following commercial and clinical advances
CapNostics
Co-founder, Chairman and CEO Lishan Aklog, M.D., Lucid Diagnostics, who was previously the co-founder of Lucid's parent company, PAVmed (PAVM) _ 2021
Founded 2018
Founded to develop an esophageal collection system and related DNA test to help detect esophageal precancer for at-risk patients suffering from GERD.
New York City, New York